Redhill Biopharma reported $8.03M in Cost of Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Adamis Pharmaceuticals ADMP:US USD 1.65M 958.41K
Cara Therapeutics CARA:US USD 3.06M 3.06M
Cronos Group Inc CRON:CN USD 19.77M 825K
Intra Cellular Therapies ITCI:US USD 5.85M 1.2M